Elobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation. Its therapeutic use is listed as laxatives. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Goofice, (R)-2-(2-(2-((3, 3-Dibutyl-7-(methylthio)-1, 1-dioxido-5-phenyl-2, 3, 4, 5-tetrahydrobenzo[b][1 and 4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetamido)acetic acid. Its PubChem CID is 9939892.
Elobixibat
| CAS No | 439087-18-0 |
|---|---|
| Molecular Formula | C36H45N3O7S2 |
| Molecular Weight | 695.9 g/mol |
| Synonyms | 2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1λ6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Elobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.
The listed CAS number is 439087-18-0.
The listed molecular formula is C36H45N3O7S2.
The listed molecular weight is 695.9 g/mol.
2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1λ6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid.
The source lists Goofice, (R)-2-(2-(2-((3, 3-Dibutyl-7-(methylthio)-1, 1-dioxido-5-phenyl-2, 3, 4, 5-tetrahydrobenzo[b][1 and 4]thiazepin-8-yl)oxy)acetamido)-2-phenylacetamido)acetic acid.